Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium
Crossref DOI link: https://doi.org/10.1007/s40261-014-0224-z
Published Online: 2014-08-28
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kongnakorn, Thitima
Lanitis, Tereza
Annemans, Lievens
Thijs, Vincent
Marbaix, Sophie
Text and Data Mining valid from 2014-08-28